Literature DB >> 18308935

A translocation causing increased alpha-klotho level results in hypophosphatemic rickets and hyperparathyroidism.

Catherine A Brownstein1, Felix Adler, Carol Nelson-Williams, Junko Iijima, Peining Li, Akihiro Imura, Yo-Ichi Nabeshima, Miguel Reyes-Mugica, Thomas O Carpenter, Richard P Lifton.   

Abstract

Phosphate homeostasis is central to diverse physiologic processes including energy homeostasis, formation of lipid bilayers, and bone formation. Reduced phosphate levels due to excessive renal loss cause hypophosphatemic rickets, a disease characterized by prominent bone defects; conversely, hyperphosphatemia, a major complication of renal failure, is accompanied by parathyroid hyperplasia, hyperparathyroidism, and osteodystrophy. Here, we define a syndrome featuring both hypophosphatemic rickets and hyperparathyroidism due to parathyroid hyperplasia as well as other skeletal abnormalities. We show that this disease is due to a de novo translocation with a breakpoint adjacent to alpha-Klotho, which encodes a beta-glucuronidase, and is implicated in aging and regulation of FGF signaling. Plasma alpha-Klotho levels and beta-glucuronidase activity are markedly increased in the affected patient; unexpectedly, the circulating FGF23 level is also markedly elevated. These findings suggest that the elevated alpha-Klotho level mimics aspects of the normal response to hyperphosphatemia and implicate alpha-Klotho in the selective regulation of phosphate levels and in the regulation of parathyroid mass and function; they also have implications for the pathogenesis and treatment of renal osteodystrophy in patients with kidney failure.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18308935      PMCID: PMC2265125          DOI: 10.1073/pnas.0712361105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  Mutational analysis and genotype-phenotype correlation of the PHEX gene in X-linked hypophosphatemic rickets.

Authors:  I A Holm; A E Nelson; B G Robinson; R S Mason; D J Marsh; C T Cowell; T O Carpenter
Journal:  J Clin Endocrinol Metab       Date:  2001-08       Impact factor: 5.958

2.  FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis.

Authors:  Takashi Shimada; Hisashi Hasegawa; Yuji Yamazaki; Takanori Muto; Rieko Hino; Yasuhiro Takeuchi; Toshiro Fujita; Kazuhiko Nakahara; Seiji Fukumoto; Takeyoshi Yamashita
Journal:  J Bone Miner Res       Date:  2003-12-29       Impact factor: 6.741

3.  PHEXdb, a locus-specific database for mutations causing X-linked hypophosphatemia.

Authors:  Y Sabbagh; A O Jones; H S Tenenhouse
Journal:  Hum Mutat       Date:  2000       Impact factor: 4.878

4.  Analysis of recombinant Phex: an endopeptidase in search of a substrate.

Authors:  R Guo; S Liu; R F Spurney; L D Quarles
Journal:  Am J Physiol Endocrinol Metab       Date:  2001-10       Impact factor: 4.310

5.  A conserved cis-acting element in the parathyroid hormone 3'-untranslated region is sufficient for regulation of RNA stability by calcium and phosphate.

Authors:  R Kilav; J Silver; T Naveh-Many
Journal:  J Biol Chem       Date:  2000-12-15       Impact factor: 5.157

Review 6.  Molecular mechanisms of secondary hyperparathyroidism.

Authors:  J Silver; R Kilav; A Sela-Brown; T Naveh-Many
Journal:  Pediatr Nephrol       Date:  2000-07       Impact factor: 3.714

7.  Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.

Authors:  Kenneth B Jonsson; Richard Zahradnik; Tobias Larsson; Kenneth E White; Toshitsugu Sugimoto; Yasuo Imanishi; Takehisa Yamamoto; Geeta Hampson; Hiroyuki Koshiyama; Osten Ljunggren; Koichi Oba; In Myung Yang; Akimitsu Miyauchi; Michael J Econs; Jeffrey Lavigne; Harald Jüppner
Journal:  N Engl J Med       Date:  2003-04-24       Impact factor: 91.245

8.  The genomic response of the mouse kidney to low-phosphate diet is altered in X-linked hypophosphatemia.

Authors:  Martha H Meyer; Emily Dulde; Ralph A Meyer
Journal:  Physiol Genomics       Date:  2004-06-17       Impact factor: 3.107

9.  Klotho is a novel beta-glucuronidase capable of hydrolyzing steroid beta-glucuronides.

Authors:  Osamu Tohyama; Akihiro Imura; Akiko Iwano; Jean-Noël Freund; Bernard Henrissat; Toshihiko Fujimori; Yo-ichi Nabeshima
Journal:  J Biol Chem       Date:  2003-12-29       Impact factor: 5.157

10.  Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis.

Authors:  Tobias Larsson; Richard Marsell; Ernestina Schipani; Claes Ohlsson; Osten Ljunggren; Harriet S Tenenhouse; Harald Jüppner; Kenneth B Jonsson
Journal:  Endocrinology       Date:  2004-02-26       Impact factor: 4.736

View more
  94 in total

Review 1.  Biology of Fibroblast Growth Factor 23: From Physiology to Pathology.

Authors:  Marie Courbebaisse; Beate Lanske
Journal:  Cold Spring Harb Perspect Med       Date:  2018-05-01       Impact factor: 6.915

Review 2.  The expanding family of hypophosphatemic syndromes.

Authors:  Thomas O Carpenter
Journal:  J Bone Miner Metab       Date:  2011-12-14       Impact factor: 2.626

3.  Identification of novel small molecules that elevate Klotho expression.

Authors:  Gwendalyn D King; CiDi Chen; Mickey M Huang; Ella Zeldich; Patricia L Brazee; Eli R Schuman; Maxime Robin; Gregory D Cuny; Marcie A Glicksman; Carmela R Abraham
Journal:  Biochem J       Date:  2012-01-01       Impact factor: 3.857

4.  Klotho: a novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule.

Authors:  Ming Chang Hu; Mingjun Shi; Jianning Zhang; Johanne Pastor; Teruyo Nakatani; Beate Lanske; M Shawkat Razzaque; Kevin P Rosenblatt; Michel G Baum; Makoto Kuro-o; Orson W Moe
Journal:  FASEB J       Date:  2010-05-13       Impact factor: 5.191

Review 5.  The role of Klotho in energy metabolism.

Authors:  M Shawkat Razzaque
Journal:  Nat Rev Endocrinol       Date:  2012-05-29       Impact factor: 43.330

Review 6.  FGF23 and Phosphate Wasting Disorders.

Authors:  Xianglan Huang; Yan Jiang; Weibo Xia
Journal:  Bone Res       Date:  2013-06-28       Impact factor: 13.567

Review 7.  The Causes of Hypo- and Hyperphosphatemia in Humans.

Authors:  Eugénie Koumakis; Catherine Cormier; Christian Roux; Karine Briot
Journal:  Calcif Tissue Int       Date:  2020-04-13       Impact factor: 4.333

8.  Biochemical and functional characterization of the klotho-VS polymorphism implicated in aging and disease risk.

Authors:  Tracey B Tucker Zhou; Gwendalyn D King; CiDi Chen; Carmela R Abraham
Journal:  J Biol Chem       Date:  2013-11-11       Impact factor: 5.157

9.  The age-regulating protein klotho is vital to sustain retinal function.

Authors:  Nicholas J Reish; Astha Maltare; Alex S McKeown; Ann M Laszczyk; Timothy W Kraft; Alecia K Gross; Gwendalyn D King
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-10-11       Impact factor: 4.799

10.  Inherited disorders of calcium and phosphate metabolism.

Authors:  Jyothsna Gattineni
Journal:  Curr Opin Pediatr       Date:  2014-04       Impact factor: 2.856

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.